David Mack and Lisa Maves are co-Principle Investigators on a new NIH R01 grant – “Three-model platform for understanding DMD epigenetic mechanisms and advancing small molecule therapies“.
Neuromuscular Disease Research Group
University of Washington, Institute for Stem Cell and Regenerative Medicine